← Back to Search

Anti-inflammatory

Colchicine for Coronary Artery Disease (Colchicine-PCI Trial)

Phase 4
Waitlist Available
Led By Binita Shah, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Referred for possible PCI
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Colchicine-PCI Trial Summary

This study is evaluating whether colchicine might reduce the risk of heart attacks in people with heart disease.

Eligible Conditions
  • Coronary Artery Disease
  • Acute Coronary Syndrome

Colchicine-PCI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Colchicine-PCI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Peri-procedural Myocardial Necrosis
Secondary outcome measures
All-cause Mortality, Non-fatal MI, or TVR
Number of Participants With All-cause Mortality, Non-fatal MI, or TVR
Number of Participants With All-cause Mortality, Non-fatal MI, or Target Vessel Revascularization (TVR)
+1 more

Colchicine-PCI Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ColchicineActive Control1 Intervention
Colchicine 1.8 mg PO over 1 hour
Group II: PlaceboPlacebo Group1 Intervention
Matching placebo

Find a Location

Who is running the clinical trial?

NYU Langone HealthOTHER
1,367 Previous Clinical Trials
839,047 Total Patients Enrolled
21 Trials studying Coronary Artery Disease
14,464 Patients Enrolled for Coronary Artery Disease
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,305,889 Total Patients Enrolled
7 Trials studying Coronary Artery Disease
8,783 Patients Enrolled for Coronary Artery Disease
Binita Shah, MDPrincipal InvestigatorManhattan Campus of the VA NY Harbor Healthcare System, New York, NY
4 Previous Clinical Trials
1,302 Total Patients Enrolled
2 Trials studying Coronary Artery Disease
980 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Colchicine in Percutaneous Coronary Intervention
2013. "Colchicine in Percutaneous Coronary Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02594111.
~60 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top